Teva-Handok to commence business activities from next month

Published: 2013-10-21 06:56:00

Updated: 2013-10-21 06:56:00

Teva-Handok, a business venture established in December between Teva Pharmaceutical Industries Ltd. and Handok Pharmaceuticals Co., is expected to commence activities from next month, according to company officials.

The business venture brings together Teva’s manufacturing expertise and portfo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK